par Metzger-Filho, Otto;Moulin, Camilo;Awada, Ahmad 
Référence Current Clinical Pharmacology, 5, 3, page (166-177)
Publication Publié, 2010-08
Référence Current Clinical Pharmacology, 5, 3, page (166-177)
Publication Publié, 2010-08
Article révisé par les pairs
| Titre: |
|
| Auteur: | Metzger-Filho, Otto; Moulin, Camilo; Awada, Ahmad |
| Informations sur la publication: | Current Clinical Pharmacology, 5, 3, page (166-177) |
| Statut de publication: | Publié, 2010-08 |
| Sujet CREF: | Cancérologie |
| Mots-clés: | Breast cancer |
| Colorectal cancer | |
| Lung cancer | |
| Resistance | |
| Targeted therapy | |
| Therapy individualization | |
| MeSH keywords: | Antineoplastic Agents -- administration & dosage -- therapeutic use |
| Drug Delivery Systems | |
| Drug Resistance, Neoplasm | |
| Forecasting | |
| Humans | |
| Individualized Medicine -- trends | |
| Molecular Targeted Therapy -- trends | |
| Neoplasms -- drug therapy | |
| Receptor, Epidermal Growth Factor -- antagonists & inhibitors -- metabolism | |
| TOR Serine-Threonine Kinases -- antagonists & inhibitors -- metabolism | |
| Note générale: | Journal Article |
| Review | |
| SCOPUS: ar.j | |
| Langue: | Anglais |
| Identificateurs: | urn:issn:1574-8847 |
| info:doi/10.2174/157488410791498716 | |
| info:pii/BSP/CCP/E-Pub/0011 | |
| info:scp/78649344228 | |
| info:pmid/20406173 |
